Subjects with isolated low HDL cholesterol
Conditions
Interventions
Anti-dyslipidemic agent (pravastatin)
placebo
Sponsors
Department of Cardiovascular Physiology and Medicine, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects with isolated HDL cholesterol
Exclusion criteria
Exclusion criteria: Subjects with low HDL cholesterol who had other cardiovascular risk factors such as elevated levels of blood pressure, cholesterol, glucose and smoking habit
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endothelial function (FMD) | — |
Secondary
| Measure | Time frame |
|---|---|
| Endothelial progenitor cell function | — |
Countries
Japan
Contacts
Public ContactYukihito Hiagshi
Hiroshima University Graduate School of Biomedical Sciences
Outcome results
None listed